TRIAXIS POLIO

This brand name is authorized in Netherlands

Active ingredients

The drug TRIAXIS POLIO contains a combination of these active pharmaceutical ingredients (APIs):

1 Diphtheria toxoid adsorbed UNII 3U7E3O07S8 - CORYNEBACTERIUM DIPHTHERIAE

Read about Diphtheria toxoid

2 Pertactin (69kD outer membrane protein) UNII 2QNL82089R - BORDETELLA PERTUSSIS

Read about Pertactin

3 Pertussis toxoid, deactivated, adsorbed

Read about Pertussis toxoid

4 Pertussis filamentous hemagglutinin adsorbed UNII 8C367IY4EY - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Read about Pertussis filamentous hemagglutinin

5 Pertussis agglutinogens, fimbrial type 2 and 3 UNII 63GD90PP8X - BORDETELLA PERTUSSIS PERTACTIN ANTIGEN

Read about Pertussis, purified antigen

6 Mahoney strain monovalent, inactivated UNII 0LVY784C09 - POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)

Read about Poliomyelitis, serotype 1

7 MEF-1 strain monovalent, inactivated UNII 23JE9KDF4R - POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)

Read about Poliomyelitis, serotype 2

8 Saukett Strain monovalent, inactivated UNII 459ROM8M9M - POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)

Read about Poliomyelitis, serotype 3

9 Tetanus toxoid, adsorbed, inactivated UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)

Read about Tetanus toxoid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07CA02	Diphtheria-pertussis-poliomyelitis-tetanus	J Antiinfectives for systemic use → J07 Vaccines → J07C Bacterial and viral vaccines, combined → J07CA Bacterial and viral vaccines, combined
Discover more medicines within J07CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 88935